High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: Results of BFM 95 study in Kuwait

Pediatric Hematology and Oncology

Volumn 20, Issue 2, 2003, Pages 103-110

  Mottl, Hubert ^a   Bajciova, Viera ^a   Nemec, Jaroslav ^a   Al Shemmari, Salem ^a   Al Awadi, Shafika ^a  

^a KUWAIT CANCER CONTROL CENTER   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINATE CALCIUM; IFOSFAMIDE; MERCAPTOPURINE; MESNA; METHOTREXATE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; BONE MARROW TOXICITY; BURKITT LYMPHOMA; CANCER THERAPY; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FAMILIAL CANCER; FEMALE; FOLLOW UP; HUMAN; INFANT; KUWAIT; LIVER TOXICITY; LYMPHOBLASTOMA; MALE; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INFANT; KUWAIT; LEUCOVORIN; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MESNA; METHOTREXATE; NEOPLASM STAGING; PREDNISOLONE; PREDNISONE; SURVIVAL RATE; THIOGUANINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0037368778     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/0880010390158603     Document Type: Article

References (19)

1. Shad A, Magrath I. Malignant non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven; 1997:545-587.
2. Sterba J, Bajciova V, Mechl Z, Al-Jazzaf H. Is it necessary to developed specific therapeutic approaches for Middle East paediatric lymphomas? Paediatric lymphomas in Kuwait Cancer Control Centre (KCCC) 1995-1996. Med Pediatr Oncol. 1997;29:451.
3. Mottl H, Bajciova V, Al-Awadi S. Cancer incidence among the pediatric population in Kuwait. 1st Regional Meeting of the International Network for Cancer Treatment and Research, Riyadh, The Kingdom of Saudi Arabia, 2000. Abstracts.
4. Magrath IT. African Burkitt's lymphoma: history, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol. 1991;13:222-246.
5. Muller-Weihrich S, Henze G, Odenwald E, et al. BFM trials for childhood non-Hodgkin's lymphomas. In: Cavalli F, Bonadonna G, Rozenswieg M, eds. Malignant Lymphomas and Hodgkin's Disease: Experimental and Therapeutic Advances. Boston: Martinus Nijhof; 1985:633-642.
6. Gutterrez M, Klashor B. Molecular epidemiology of Burkitt lymphoma from South America: differences in break-point location and Epstein-Barr virus association from tumors in other world regions. Blood. 1992;79:3261-3266.
7. Yaniv I, Fischer S, Mor C, et al. Improved outcome in childhood B-cell lymphoma with intensified French LMB protocol. Med Pediatr Oncol. 2000;35:8-12.
8. Parkin DM, Stiller CA, Draper GJ, et al. The international incidence of childhood cancer. Int J Cancer. 1988;42:511-520.
9. Patte C, Philip T. High survival rate in advanced stage B cell lymphoma and leukemia without CNS involvement with a short intensive polychemotherapy: results from French Pediatric Oncology Society randomized trial of 216 children. J Clin Oncol. 1991;9:123-132.
10. Magrath I. The pathogenesis of Burkitt lymphoma. Adv Cancer Res. 1990;55:133-270.
11. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster group trial NHL-BFM 90. 1999;94:3294-3306.
12. Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biological subtypes and stage: a report of the BFM group. J Clin Oncol. 1995;13:359.
13. Berg H van den, Zsiros J, Veneberg A, et al. Favorable outcome after 1-year treatment of childhood T-cell lymphoma/T-cell acute lymphoblastic leukemia. Med Pediatr. Oncol. 1998;30:46-51.
14. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel Classification for lymphomas. Lancet. 1988;1:292.
15. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332-339.
16. Bowman WP, Shuster JJ, Cook B, et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a Pediatric Oncology, Group Study. J Clin Oncol. 1996;14:1252.
17. Magrath I. The non-Hodgkin's lymphomas in children. New trends in management of lymphoma. Kuwait 2000;108-111.
18. Wollner N, Burchenal JH, Lieberman PH, et al. Non-Hodgkin's lymphoma in children: a comparative study of two modalities of therapy. Cancer. 1976;37:123-134.
19. Patte C, Kalifa C, Flamant F, et al. Results of LMT81 protocol, a modified LSA2-L2 protocol with high dose methotrexate, on 84 children with non-B-cell/lymphoblastic/lymphoma. Med Pediatr Oncol. 1992;20:105-113.